Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Uniform financing of services

Turning three into one: rethinking the financing system

    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
  • 2 minute read

Uniform financing of benefits (EFAS) is intended to promote coordinated care and at the same time make benefits more affordable for premium payers. What will change for insured persons, insurers, cantons and long-term care.

Outpatient services are currently financed exclusively by the health insurers, while inpatient services are covered jointly by the insurers and the cantons: The cantons – and therefore the taxpayers – bear 55% of the costs, while the insurers – and therefore the insured persons – bear the remaining 45%. Both insurers and patients make limited contributions to the costs of care services in nursing homes and at home. The amount of these contributions is determined by the Federal Council. The cantons are responsible for the remaining funding. With uniform financing, these three financing systems will be replaced by a single one. All health insurance benefits are financed by the cantons and insurers according to the same distribution formula: 26.9% of the net costs (i.e. after deduction of the deductible and the insured person’s excess) by the cantons and 73.1% by the insurers. In this way, funding no longer depends on the type of benefit. Patients will only continue to pay a limited contribution towards the costs of care services, which will continue to be determined by the Federal Council.

The main aim of this reform is to improve the quality of care. At the same time, healthcare services are to become more affordable for premium payers and various disincentives are to be removed. Uniform funding is therefore intended to accelerate the shift from inpatient to outpatient care. In addition, EFAS puts an end to cost shifting at the expense of premium payers.

Changes at a glance

Over the last ten years, the percentage increase in costs borne by insurers – and therefore the rise in premiums – has been significantly higher than the increase in costs borne by the cantons. This is due to the fact that the cantons do not contribute to the rapidly rising costs of outpatient services (with the exception of nursing care), but only to the less rapidly rising costs of inpatient services. Uniform financing puts an end to this cost shift at the expense of premium payers. For most service providers, however, little will change. Nevertheless, the uniform financing also brings with it certain changes: in future, insurers will have more incentives to promote the provision of outpatient services and coordination. The outpatient hospital sector, coordinated care networks and GPs could benefit from this.

Source: www.bag.admin.ch/bag/de/home/versicherungen/krankenversicherung/krankenversicherung-revisionsprojekte/parlamentarische-initiative-finanzierung-der-gesundheitsleistungen-aus-einer-hand-einfuehrung-des-monismus/efas-fragen-und-antworten.html (last accessed on 18.05.2024).

InFo NEUROLOGY & PSYCHIATRY 2024; 22(3): 40 (published on 31.5.24, ahead of print)

Related Topics
  • EFAS
  • financing system
  • Performance financing
Previous Article
  • Mild cognitive impairment (MCI)

Ginkgo biloba extract promotes dual-task gait safety

  • General Internal Medicine
  • Geriatrics
  • Neurology
  • ORL
  • Pharmaceutical medicine
  • RX
  • Studies
View Post
Next Article
  • Eosinophilic esophagitis (EoE)

Th2 inflammation plays a central role

  • Allergology and clinical immunology
  • Congress Reports
  • Dermatology and venereology
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • Nutrition
  • ORL
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 8 min
  • Hyperhidrosis: Keep a Cool Head

An Overview of Important Treatment Options

    • RX
    • Dermatology and venereology
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • This article was sponsored by Johnson & Johnson.

Give your patients a chance to live longer without progression with TECVAYLI® + DARZALEX® compared to DPd/DVd1

    • RX
    • Hematology
    • Oncology
    • Partner Content
    • Studies
View Post
  • 6 min
  • Sjögren's Syndrome in Early Childhood

Children often develop lymphomas

    • RX
    • Education
    • Pediatrics
    • Rheumatology
    • Studies
View Post
  • 12 min
  • Multidrug-Resistant Pathogens in Wound Care

An Enemy in the Microbiome?

    • Dermatology and venereology
    • CME continuing education
    • Infectiology
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
    • Surgery
View Post
  • 14 min
  • Rare Genodermatoses: From Diagnosis to Treatment

Darier’s Disease, also known as Follicular Keratosis – Update 2026

    • CME continuing education
    • Cases
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 9 min
  • Psychedelic-assisted therapy

Current status of PAT

    • RX
    • CME continuing education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 7 min
  • Osgood-Schlatter Disease

Clinical Presentation, Diagnosis, and Treatment

    • RX
    • Cases
    • Education
    • Orthopedics
    • Pediatrics
View Post
  • 4 min
  • Cardiovascular Risk in Rheumatoid Arthritis

What is the most dangerous thing for RA?

    • RX
    • Cardiology
    • Education
    • General Internal Medicine
    • Rheumatology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Darier’s Disease, also known as Follicular Keratosis – Update 2026
  • 2
    An Enemy in the Microbiome?
  • 3
    Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
  • 4
    Current status of PAT
  • 5
    Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.